Madison S. Carlino is a policy analyst at Reason Foundation. Her work primarily focuses on drug policy in the United States, including psychedelic medicine and marijuana laws.
-
Washington has a chance to examine ibogaine-assisted therapy benefits
Washington Senate Bill 5204 would allow research into ibogaine-assisted therapy, a promising potential treatment for opioid use disorder.
-
DEA’s increased DMT quota signals positive advancement in psychedelic research
The Drug Enforcement Administration has raised the 2025 legal production quota for the psychedelic DMT from 11,000 grams to 20,000 grams.
-
Rethinking the need for double-blind placebo trials in psychedelic clinical investigations
Alternative trial designs recognize the distinct nature of psychedelics and ensure that promising therapies can meet regulatory standards.
-
Psychedelic treatment for neurodegenerative disorders
Recent research suggests that psychedelics, such as psilocybin and LSD, show strong potential as effective treatments for neurodegenerative disorders.
-
Psychedelic therapy offers possible new hope for Alzheimer’s disease sufferers
Nearly 6.9 million Americans aged 65 and older suffer from Alzheimer’s, facing a progressive decline that current treatments cannot stop or reverse.
-
Batch-tracking: The next wave of marijuana tracking systems
Maine recently implemented a first-of-its-kind system to track marijuana sales, setting a new standard for the industry.
-
No, Florida’s marijuana measure won’t create a cannabis monopoly—as long as lawmakers don’t screw it up
Preventing monopolization in Florida’s marijuana market requires focusing on creating accessible and fair conditions for all businesses.
-
Examining court rulings and state and federal laws on marijuana users’ gun rights
Government should not be able to restrict an individual’s Second Amendment right to possess a firearm due to their legal marijuana consumption.
-
Colorado could improve regulatory rules regarding psychedelic use
As Colorado establishes an operating regulatory framework for The Natural Medicine Health Act, there is room for improvement in rulemaking.
-
Alaska considers much needed reduction in marijuana taxes
A drastic tax cut is warranted to place legal products on a more even playing field with illicit alternatives.
-
Examining the 2024 state marijuana legalization proposals
Right now, 24 states have legalized the recreational use of marijuana by adults—a rapid shift after Colorado and Washington first did so in 2012.
-
Ibogaine treatment for opioid use disorder
Policymakers should consider ibogaine as a potential alternative treatment for opioid use disorder.
-
Florida’s attorney general challenges marijuana initiative with spurious arguments
Florida voters have the chance to vote on a marijuana ballot initiative, but Florida politicians are trying to keep that from happening.
-
Survey shows stereotype of the lazy, lefty marijuana smoker doesn’t reflect reality
Marijuana users come from all different backgrounds and are not restricted to a particular political affiliation, education level, income bracket, career position, or location.
-
The Breakthrough Therapies Act could spur research and improve access to life-saving drugs
The Breakthrough Therapies Act would pave the way for more accessible and innovative mental health treatments while also enabling state-level adaptation.
-
The long road to Kentucky’s limited medical marijuana legalization
Participants in the new Kentucky medical program will face limitations not typically found in most states, including a continued ban on smoking marijuana.
-
Research showing the tremendous therapeutic potential of psychedelics
In clinical trials, one-third of patients who showed no response to at least two other forms of treatment for depression demonstrated lasting remission following a single treatment with psilocybin.
-
Federal legislation to protect Second Amendment rights of legal cannabis users
The GRAM Act would ensure that individuals are not forced to choose between exercising their constitutional rights to own a gun and legally using cannabis.